However, the above-mentioned vaccinations did not induce any antitumor effects on p388 tumor-bearing mice (data not shown), indicating that CD4+ T LEX-CD8086 cells can induce potent therapeutic effects via promoting CD8+ T cells proliferation and differentiation into leukemia antigen-specific CD8+ CTL. This evidence concerns the gene CD8A and leukemia.